$ICPT Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in INTERCEPT PHARMACEUTICALS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in INTERCEPT PHARMACEUTICALS, INC.. Get notifications about new insider transactions in INTERCEPT PHARMACEUTICALS, INC. for free.
Page: < prev 1 2 3 4 5 6 7 ... 13 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Apr 03 2019 | ICPT | INTERCEPT PHARMACE ... | Bright Lisa | President, Internat ... | Sell | S | 115.01 | 594 | 68,316 | 20,982 | 21.6 K to 21 K (-2.75 %) |
Apr 03 2019 | ICPT | INTERCEPT PHARMACE ... | Bright Lisa | President, Internat ... | Payment of Exercise | F | 111.50 | 531 | 59,207 | 21,576 | 22.1 K to 21.6 K (-2.40 %) |
Apr 03 2019 | ICPT | INTERCEPT PHARMACE ... | Weyer Christian | EVP, Research & Dev ... | Payment of Exercise | F | 111.50 | 46 | 5,129 | 19,061 | 19.1 K to 19.1 K (-0.24 %) |
Apr 03 2019 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | Chief Medical Offic ... | Sell | S | 115.01 | 562 | 64,636 | 39,499 | 40.1 K to 39.5 K (-1.40 %) |
Apr 03 2019 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | Chief Medical Offic ... | Payment of Exercise | F | 111.50 | 482 | 53,743 | 40,061 | 40.5 K to 40.1 K (-1.19 %) |
Apr 03 2019 | ICPT | INTERCEPT PHARMACE ... | Kim Richard J | President US Comm & ... | Payment of Exercise | F | 111.50 | 267 | 29,771 | 17,470 | 17.7 K to 17.5 K (-1.51 %) |
Apr 03 2019 | ICPT | INTERCEPT PHARMACE ... | Kapadia Sandip | CFO and Treasurer | Payment of Exercise | F | 111.50 | 615 | 68,573 | 27,308 | 27.9 K to 27.3 K (-2.20 %) |
Apr 03 2019 | ICPT | INTERCEPT PHARMACE ... | Ford David A | Chief Human Resourc ... | Payment of Exercise | F | 111.50 | 92 | 10,258 | 12,694 | 12.8 K to 12.7 K (-0.72 %) |
Apr 03 2019 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | President & CEO | Payment of Exercise | F | 111.50 | 1,547 | 172,491 | 472,221 | 473.8 K to 472.2 K (-0.33 %) |
Mar 29 2019 | ICPT | INTERCEPT PHARMACE ... | Fundaro Paolo | Director | Sell | S | 107.45 | 2,171 | 233,272 | 11,114 | 13.3 K to 11.1 K (-16.34 %) |
Mar 01 2019 | ICPT | INTERCEPT PHARMACE ... | Weyer Christian | EVP, Research & Dev ... | Sell | S | 103.16 | 333 | 34,352 | 19,107 | 19.4 K to 19.1 K (-1.71 %) |
Mar 01 2019 | ICPT | INTERCEPT PHARMACE ... | Weyer Christian | EVP, Research & Dev ... | Payment of Exercise | F | 92.76 | 364 | 33,765 | 19,440 | 19.8 K to 19.4 K (-1.84 %) |
Mar 01 2019 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | Chief Medical Offic ... | Option Exercise | M | 31.90 | 2,000 | 63,800 | 13,031 | |
Mar 01 2019 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | Chief Medical Offic ... | Sell | S | 103.16 | 2,000 | 206,320 | 40,543 | 42.5 K to 40.5 K (-4.70 %) |
Mar 01 2019 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | Chief Medical Offic ... | Buy | M | 31.90 | 2,000 | 63,800 | 42,543 | 40.5 K to 42.5 K (+4.93 %) |
Feb 26 2019 | ICPT | INTERCEPT PHARMACE ... | Durso Jerome Benedict | Chief Operating Off ... | Payment of Exercise | F | 93.35 | 319 | 29,779 | 34,046 | 34.4 K to 34 K (-0.93 %) |
Feb 21 2019 | ICPT | INTERCEPT PHARMACE ... | AKKARAJU SRINIVAS | Director | Sell | S | 128.78 | 23,438 | 3,018,346 | 210,937 | 234.4 K to 210.9 K (-10.00 %) |
Feb 20 2019 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | Chief Medical Offic ... | Option Exercise | M | 31.90 | 2,000 | 63,800 | 15,031 | |
Feb 20 2019 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | Chief Medical Offic ... | Option Exercise | M | 31.90 | 2,000 | 63,800 | 15,031 | |
Feb 20 2019 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | Chief Medical Offic ... | Sell | S | 111.51 | 2,000 | 223,020 | 40,543 | 42.5 K to 40.5 K (-4.70 %) |
Feb 20 2019 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | Chief Medical Offic ... | Sell | S | 111.51 | 2,000 | 223,020 | 40,543 | 42.5 K to 40.5 K (-4.70 %) |
Feb 20 2019 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | Chief Medical Offic ... | Buy | M | 31.90 | 2,000 | 63,800 | 42,543 | 40.5 K to 42.5 K (+4.93 %) |
Feb 20 2019 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | Chief Medical Offic ... | Buy | M | 31.90 | 2,000 | 63,800 | 42,543 | 40.5 K to 42.5 K (+4.93 %) |
Feb 14 2019 | ICPT | INTERCEPT PHARMACE ... | Sullivan Ryan T | General Counsel and ... | Payment of Exercise | F | 110.35 | 1,971 | 217,500 | 27,829 | 29.8 K to 27.8 K (-6.61 %) |
Feb 14 2019 | ICPT | INTERCEPT PHARMACE ... | Cawkwell Gail | SVP, Med Affairs, S ... | Payment of Exercise | F | 111.05 | 1,276 | 141,700 | 17,849 | 19.1 K to 17.8 K (-6.67 %) |
Feb 11 2019 | ICPT | INTERCEPT PHARMACE ... | Ford David A | Chief Human Resourc ... | Payment of Exercise | F | 118.90 | 125 | 14,863 | 12,786 | 12.9 K to 12.8 K (-0.97 %) |
Jan 18 2019 | ICPT | INTERCEPT PHARMACE ... | Kim Richard J | President US Comm & ... | Option Exercise | A | 110.80 | 6,400 | 709,120 | 6,400 | |
Jan 18 2019 | ICPT | INTERCEPT PHARMACE ... | Kim Richard J | President US Comm & ... | Grant | A | 0.00 | 4,000 | 0 | 17,737 | 13.7 K to 17.7 K (+29.12 %) |
Jan 18 2019 | ICPT | INTERCEPT PHARMACE ... | Weyer Christian | EVP, Research & Dev ... | Option Exercise | A | 110.80 | 6,800 | 753,440 | 6,800 | |
Jan 18 2019 | ICPT | INTERCEPT PHARMACE ... | Weyer Christian | EVP, Research & Dev ... | Grant | A | 0.00 | 4,200 | 0 | 19,804 | 15.6 K to 19.8 K (+26.92 %) |
Jan 18 2019 | ICPT | INTERCEPT PHARMACE ... | Sullivan Ryan T | General Counsel and ... | Option Exercise | A | 110.80 | 10,700 | 1,185,560 | 10,700 | |
Jan 18 2019 | ICPT | INTERCEPT PHARMACE ... | Sullivan Ryan T | General Counsel and ... | Grant | A | 0.00 | 6,600 | 0 | 29,800 | 23.2 K to 29.8 K (+28.45 %) |
Jan 18 2019 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | Chief Medical Offic ... | Option Exercise | A | 110.80 | 5,300 | 587,240 | 5,300 | |
Jan 18 2019 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | Chief Medical Offic ... | Grant | A | 0.00 | 3,300 | 0 | 40,543 | 37.2 K to 40.5 K (+8.86 %) |
Jan 18 2019 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | President & CEO | Option Exercise | A | 110.80 | 13,700 | 1,517,960 | 13,700 | |
Jan 18 2019 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | President & CEO | Grant | A | 0.00 | 8,500 | 0 | 573,768 | 565.3 K to 573.8 K (+1.50 %) |
Jan 18 2019 | ICPT | INTERCEPT PHARMACE ... | Kapadia Sandip | CFO and Treasurer | Option Exercise | A | 110.80 | 7,200 | 797,760 | 7,200 | |
Jan 18 2019 | ICPT | INTERCEPT PHARMACE ... | Kapadia Sandip | CFO and Treasurer | Grant | A | 0.00 | 4,500 | 0 | 27,923 | 23.4 K to 27.9 K (+19.21 %) |
Jan 18 2019 | ICPT | INTERCEPT PHARMACE ... | Ford David A | Chief Human Resourc ... | Option Exercise | A | 110.80 | 6,100 | 675,880 | 6,100 | |
Jan 18 2019 | ICPT | INTERCEPT PHARMACE ... | Ford David A | Chief Human Resourc ... | Grant | A | 0.00 | 3,800 | 0 | 12,911 | 9.1 K to 12.9 K (+41.71 %) |
Jan 18 2019 | ICPT | INTERCEPT PHARMACE ... | Durso Jerome Benedict | Chief Operating Off ... | Option Exercise | A | 110.80 | 15,200 | 1,684,160 | 15,200 | |
Jan 18 2019 | ICPT | INTERCEPT PHARMACE ... | Durso Jerome Benedict | Chief Operating Off ... | Grant | A | 0.00 | 9,400 | 0 | 34,365 | 25 K to 34.4 K (+37.65 %) |
Jan 18 2019 | ICPT | INTERCEPT PHARMACE ... | Cawkwell Gail | SVP, Med Affairs, S ... | Option Exercise | A | 110.80 | 6,700 | 742,360 | 6,700 | |
Jan 18 2019 | ICPT | INTERCEPT PHARMACE ... | Cawkwell Gail | SVP, Med Affairs, S ... | Grant | A | 0.00 | 4,100 | 0 | 19,125 | 15 K to 19.1 K (+27.29 %) |
Jan 18 2019 | ICPT | INTERCEPT PHARMACE ... | Bright Lisa | President, Internat ... | Option Exercise | A | 110.80 | 5,300 | 587,240 | 5,300 | |
Jan 18 2019 | ICPT | INTERCEPT PHARMACE ... | Bright Lisa | President, Internat ... | Grant | A | 0.00 | 3,300 | 0 | 22,107 | 18.8 K to 22.1 K (+17.55 %) |
Jan 15 2019 | ICPT | INTERCEPT PHARMACE ... | Kim Richard J | President US Comm & ... | Payment of Exercise | F | 109.73 | 77 | 8,449 | 13,737 | 13.8 K to 13.7 K (-0.56 %) |
Jan 09 2019 | ICPT | INTERCEPT PHARMACE ... | Bright Lisa | President, Internat ... | Sell | S | 104.93 | 1,313 | 137,773 | 18,807 | 20.1 K to 18.8 K (-6.53 %) |
Jan 04 2019 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | Chief Medical Offic ... | Sell | S | 97.48 | 474 | 46,206 | 37,243 | 37.7 K to 37.2 K (-1.26 %) |
Jan 03 2019 | ICPT | INTERCEPT PHARMACE ... | Weyer Christian | EVP, Research & Dev ... | Payment of Exercise | F | 100.79 | 215 | 21,670 | 15,604 | 15.8 K to 15.6 K (-1.36 %) |
Jan 03 2019 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | Chief Medical Offic ... | Option Exercise | M | 31.90 | 2,000 | 63,800 | 17,031 | |
Jan 03 2019 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | Chief Medical Offic ... | Sell | S | 97.45 | 699 | 68,118 | 37,717 | 38.4 K to 37.7 K (-1.82 %) |
Jan 03 2019 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | Chief Medical Offic ... | Sell | S | 98.28 | 2,000 | 196,560 | 38,416 | 40.4 K to 38.4 K (-4.95 %) |
Jan 03 2019 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | Chief Medical Offic ... | Buy | M | 31.90 | 2,000 | 63,800 | 40,416 | 38.4 K to 40.4 K (+5.21 %) |
Jan 03 2019 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | Chief Medical Offic ... | Payment of Exercise | F | 100.79 | 736 | 74,181 | 38,416 | 39.2 K to 38.4 K (-1.88 %) |
Jan 03 2019 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | President & CEO | Payment of Exercise | F | 100.79 | 1,537 | 154,914 | 565,268 | 566.8 K to 565.3 K (-0.27 %) |
Dec 19 2018 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | Chief Medical Offic ... | Option Exercise | M | 31.90 | 2,000 | 63,800 | 19,031 | |
Dec 19 2018 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | Chief Medical Offic ... | Sell | S | 106.62 | 2,000 | 213,240 | 39,152 | 41.2 K to 39.2 K (-4.86 %) |
Dec 19 2018 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | Chief Medical Offic ... | Buy | M | 31.90 | 2,000 | 63,800 | 41,152 | 39.2 K to 41.2 K (+5.11 %) |
Dec 06 2018 | ICPT | INTERCEPT PHARMACE ... | Bright Lisa | President, Internat ... | Sell | S | 111.00 | 300 | 33,300 | 21,288 | 21.6 K to 21.3 K (-1.39 %) |
Dec 06 2018 | ICPT | INTERCEPT PHARMACE ... | Bright Lisa | President, Internat ... | Sell | S | 113.22 | 200 | 22,645 | 21,588 | 21.8 K to 21.6 K (-0.92 %) |
Dec 06 2018 | ICPT | INTERCEPT PHARMACE ... | Bright Lisa | President, Internat ... | Sell | S | 112.12 | 700 | 78,486 | 21,788 | 22.5 K to 21.8 K (-3.11 %) |
Dec 06 2018 | ICPT | INTERCEPT PHARMACE ... | Bright Lisa | President, Internat ... | Sell | S | 111.23 | 3,800 | 422,691 | 22,488 | 26.3 K to 22.5 K (-14.46 %) |
Dec 03 2018 | ICPT | INTERCEPT PHARMACE ... | Micheli Francesco | Sell | S | 105.07 | 750,000 | 78,802,500 | 6,095,578 | 6.8 M to 6.1 M (-10.96 %) | |
Dec 03 2018 | ICPT | INTERCEPT PHARMACE ... | Genextra S.p.A. | Sell | S | 105.07 | 750,000 | 78,802,500 | 6,095,578 | 6.8 M to 6.1 M (-10.96 %) | |
Nov 29 2018 | ICPT | INTERCEPT PHARMACE ... | Weyer Christian | EVP, Research & Dev ... | Sell | S | 113.78 | 1,343 | 152,807 | 15,819 | 17.2 K to 15.8 K (-7.83 %) |
Nov 29 2018 | ICPT | INTERCEPT PHARMACE ... | Weyer Christian | EVP, Research & Dev ... | Payment of Exercise | F | 108.66 | 1,438 | 156,253 | 17,162 | 18.6 K to 17.2 K (-7.73 %) |
Nov 27 2018 | ICPT | INTERCEPT PHARMACE ... | Durso Jerome Benedict | Chief Operating Off ... | Payment of Exercise | F | 111.07 | 460 | 51,092 | 26,184 | 26.6 K to 26.2 K (-1.73 %) |
Nov 27 2018 | ICPT | INTERCEPT PHARMACE ... | Bright Lisa | President, Internat ... | Payment of Exercise | F | 111.07 | 247 | 27,434 | 26,288 | 26.5 K to 26.3 K (-0.93 %) |
Nov 16 2018 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | President & CEO | Option Exercise | M | 8.67 | 27,606 | 239,253 | 39 | |
Nov 16 2018 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | President & CEO | Option Exercise | M | 8.67 | 22,394 | 194,082 | 27,645 | |
Nov 16 2018 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | President & CEO | Sell | S | 103.29 | 1,988 | 205,333 | 566,805 | 568.8 K to 566.8 K (-0.35 %) |
Nov 16 2018 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | President & CEO | Sell | S | 102.61 | 7,839 | 804,374 | 568,793 | 576.6 K to 568.8 K (-1.36 %) |
Nov 16 2018 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | President & CEO | Sell | S | 101.48 | 7,949 | 806,687 | 576,632 | 584.6 K to 576.6 K (-1.36 %) |
Nov 16 2018 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | President & CEO | Sell | S | 100.38 | 9,830 | 986,735 | 584,581 | 594.4 K to 584.6 K (-1.65 %) |
Nov 16 2018 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | President & CEO | Buy | M | 8.67 | 27,606 | 239,253 | 594,411 | 566.8 K to 594.4 K (+4.87 %) |
Nov 16 2018 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | President & CEO | Sell | S | 101.13 | 3,521 | 356,088 | 566,805 | 570.3 K to 566.8 K (-0.62 %) |
Nov 16 2018 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | President & CEO | Sell | S | 100.38 | 18,873 | 1,894,496 | 570,326 | 589.2 K to 570.3 K (-3.20 %) |
Nov 16 2018 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | President & CEO | Buy | M | 8.67 | 22,394 | 194,082 | 589,199 | 566.8 K to 589.2 K (+3.95 %) |
Nov 09 2018 | ICPT | INTERCEPT PHARMACE ... | Ford David A | Chief Human Resourc ... | Payment of Exercise | F | 113.79 | 128 | 14,565 | 9,534 | 9.7 K to 9.5 K (-1.32 %) |
Nov 02 2018 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | Chief Medical Offic ... | Option Exercise | M | 21.50 | 2,000 | 43,000 | 361 | |
Nov 02 2018 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | Chief Medical Offic ... | Sell | S | 96.32 | 2,000 | 192,640 | 39,152 | 41.2 K to 39.2 K (-4.86 %) |
Nov 02 2018 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | Chief Medical Offic ... | Buy | M | 21.50 | 2,000 | 43,000 | 41,152 | 39.2 K to 41.2 K (+5.11 %) |
Oct 16 2018 | ICPT | INTERCEPT PHARMACE ... | Kim Richard J | President US Comm & ... | Payment of Exercise | F | 103.73 | 77 | 7,987 | 14,516 | 14.6 K to 14.5 K (-0.53 %) |
Oct 16 2018 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | Chief Medical Offic ... | Option Exercise | M | 21.50 | 3,425 | 73,638 | 2,361 | |
Oct 16 2018 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | Chief Medical Offic ... | Sell | S | 102.95 | 3,425 | 352,604 | 39,152 | 42.6 K to 39.2 K (-8.04 %) |
Oct 16 2018 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | Chief Medical Offic ... | Buy | M | 21.50 | 3,425 | 73,638 | 42,577 | 39.2 K to 42.6 K (+8.75 %) |
Oct 05 2018 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | Chief Medical Offic ... | Sell | S | 110.65 | 759 | 83,983 | 39,152 | 39.9 K to 39.2 K (-1.90 %) |
Oct 03 2018 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | Chief Medical Offic ... | Payment of Exercise | F | 126.46 | 426 | 53,872 | 39,911 | 40.3 K to 39.9 K (-1.06 %) |
Oct 03 2018 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | Chief Medical Offic ... | Payment of Exercise | F | 83.91 | 416 | 34,907 | 39,911 | 40.3 K to 39.9 K (-1.03 %) |
Oct 03 2018 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | Chief Medical Offic ... | Payment of Exercise | F | 61.52 | 423 | 26,023 | 39,911 | 40.3 K to 39.9 K (-1.05 %) |
Oct 03 2018 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | Chief Medical Offic ... | Payment of Exercise | F | 58.42 | 1,020 | 59,588 | 39,911 | 40.9 K to 39.9 K (-2.49 %) |
Oct 03 2018 | ICPT | INTERCEPT PHARMACE ... | Kim Richard J | President US Comm & ... | Payment of Exercise | F | 126.46 | 144 | 18,210 | 14,593 | 14.7 K to 14.6 K (-0.98 %) |
Oct 03 2018 | ICPT | INTERCEPT PHARMACE ... | Kim Richard J | President US Comm & ... | Payment of Exercise | F | 97.10 | 77 | 7,477 | 14,593 | 14.7 K to 14.6 K (-0.52 %) |
Oct 03 2018 | ICPT | INTERCEPT PHARMACE ... | Kim Richard J | President US Comm & ... | Payment of Exercise | F | 83.91 | 144 | 12,083 | 14,593 | 14.7 K to 14.6 K (-0.98 %) |
Oct 03 2018 | ICPT | INTERCEPT PHARMACE ... | Kim Richard J | President US Comm & ... | Payment of Exercise | F | 73.07 | 77 | 5,626 | 14,593 | 14.7 K to 14.6 K (-0.52 %) |
Oct 03 2018 | ICPT | INTERCEPT PHARMACE ... | Kim Richard J | President US Comm & ... | Payment of Exercise | F | 61.52 | 144 | 8,859 | 14,593 | 14.7 K to 14.6 K (-0.98 %) |
Oct 03 2018 | ICPT | INTERCEPT PHARMACE ... | Kim Richard J | President US Comm & ... | Payment of Exercise | F | 54.21 | 1,101 | 59,685 | 14,593 | 15.7 K to 14.6 K (-7.02 %) |
Oct 03 2018 | ICPT | INTERCEPT PHARMACE ... | Kim Richard J | President US Comm & ... | Payment of Exercise | F | 54.95 | 89 | 4,891 | 14,593 | 14.7 K to 14.6 K (-0.61 %) |
Oct 03 2018 | ICPT | INTERCEPT PHARMACE ... | Kim Richard J | President US Comm & ... | Payment of Exercise | F | 58.42 | 552 | 32,248 | 14,593 | 15.1 K to 14.6 K (-3.64 %) |
Oct 03 2018 | ICPT | INTERCEPT PHARMACE ... | Kim Richard J | President US Comm & ... | Payment of Exercise | F | 65.49 | 84 | 5,501 | 14,593 | 14.7 K to 14.6 K (-0.57 %) |
Oct 03 2018 | ICPT | INTERCEPT PHARMACE ... | Bright Lisa | President, Internat ... | Payment of Exercise | F | 126.46 | 521 | 65,886 | 26,535 | 27.1 K to 26.5 K (-1.93 %) |
Oct 03 2018 | ICPT | INTERCEPT PHARMACE ... | Bright Lisa | President, Internat ... | Payment of Exercise | F | 108.45 | 247 | 26,787 | 26,535 | 26.8 K to 26.5 K (-0.92 %) |
Oct 03 2018 | ICPT | INTERCEPT PHARMACE ... | Bright Lisa | President, Internat ... | Payment of Exercise | F | 83.91 | 521 | 43,717 | 26,535 | 27.1 K to 26.5 K (-1.93 %) |
Oct 03 2018 | ICPT | INTERCEPT PHARMACE ... | Bright Lisa | President, Internat ... | Payment of Exercise | F | 70.21 | 414 | 29,067 | 26,535 | 26.9 K to 26.5 K (-1.54 %) |
Oct 03 2018 | ICPT | INTERCEPT PHARMACE ... | Bright Lisa | President, Internat ... | Grant | A | 0.00 | 879 | 0 | 26,535 | 25.7 K to 26.5 K (+3.43 %) |
Oct 03 2018 | ICPT | INTERCEPT PHARMACE ... | Bright Lisa | President, Internat ... | Payment of Exercise | F | 69.76 | 247 | 17,231 | 26,535 | 26.8 K to 26.5 K (-0.92 %) |
Oct 03 2018 | ICPT | INTERCEPT PHARMACE ... | Bright Lisa | President, Internat ... | Payment of Exercise | F | 61.52 | 522 | 32,113 | 26,535 | 27.1 K to 26.5 K (-1.93 %) |
Oct 03 2018 | ICPT | INTERCEPT PHARMACE ... | Bright Lisa | President, Internat ... | Payment of Exercise | F | 62.04 | 247 | 15,324 | 26,535 | 26.8 K to 26.5 K (-0.92 %) |
Oct 03 2018 | ICPT | INTERCEPT PHARMACE ... | Bright Lisa | President, Internat ... | Payment of Exercise | F | 53.66 | 414 | 22,215 | 26,535 | 26.9 K to 26.5 K (-1.54 %) |
Oct 03 2018 | ICPT | INTERCEPT PHARMACE ... | Bright Lisa | President, Internat ... | Payment of Exercise | F | 58.42 | 935 | 54,623 | 26,535 | 27.5 K to 26.5 K (-3.40 %) |
Oct 03 2018 | ICPT | INTERCEPT PHARMACE ... | Bright Lisa | President, Internat ... | Payment of Exercise | F | 62.08 | 414 | 25,701 | 26,535 | 26.9 K to 26.5 K (-1.54 %) |
Oct 03 2018 | ICPT | INTERCEPT PHARMACE ... | Bright Lisa | President, Internat ... | Payment of Exercise | F | 63.20 | 247 | 15,610 | 26,535 | 26.8 K to 26.5 K (-0.92 %) |
Oct 03 2018 | ICPT | INTERCEPT PHARMACE ... | Kapadia Sandip | CFO and Treasurer | Payment of Exercise | F | 126.46 | 531 | 67,150 | 24,541 | 25.1 K to 24.5 K (-2.12 %) |
Oct 03 2018 | ICPT | INTERCEPT PHARMACE ... | Kapadia Sandip | CFO and Treasurer | Payment of Exercise | F | 83.91 | 468 | 39,270 | 24,541 | 25 K to 24.5 K (-1.87 %) |
Oct 03 2018 | ICPT | INTERCEPT PHARMACE ... | Kapadia Sandip | CFO and Treasurer | Payment of Exercise | F | 61.52 | 468 | 28,791 | 24,541 | 25 K to 24.5 K (-1.87 %) |
Oct 03 2018 | ICPT | INTERCEPT PHARMACE ... | Kapadia Sandip | CFO and Treasurer | Payment of Exercise | F | 58.42 | 1,107 | 64,671 | 24,541 | 25.6 K to 24.5 K (-4.32 %) |
Oct 03 2018 | ICPT | INTERCEPT PHARMACE ... | Durso Jerome Benedict | Chief Operating Off ... | Payment of Exercise | F | 107.63 | 319 | 34,334 | 26,644 | 27 K to 26.6 K (-1.18 %) |
Oct 03 2018 | ICPT | INTERCEPT PHARMACE ... | Durso Jerome Benedict | Chief Operating Off ... | Payment of Exercise | F | 69.96 | 319 | 22,317 | 26,644 | 27 K to 26.6 K (-1.18 %) |
Oct 03 2018 | ICPT | INTERCEPT PHARMACE ... | Durso Jerome Benedict | Chief Operating Off ... | Payment of Exercise | F | 62.04 | 1,318 | 81,769 | 26,644 | 28 K to 26.6 K (-4.71 %) |
Oct 03 2018 | ICPT | INTERCEPT PHARMACE ... | Ford David A | Chief Human Resourc ... | Payment of Exercise | F | 116.84 | 128 | 14,956 | 9,662 | 9.8 K to 9.7 K (-1.31 %) |
Oct 03 2018 | ICPT | INTERCEPT PHARMACE ... | Ford David A | Chief Human Resourc ... | Payment of Exercise | F | 70.15 | 510 | 35,777 | 9,662 | 10.2 K to 9.7 K (-5.01 %) |
Oct 03 2018 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | President & CEO | Payment of Exercise | F | 126.46 | 2,049 | 259,117 | 566,805 | 568.9 K to 566.8 K (-0.36 %) |
Oct 03 2018 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | President & CEO | Payment of Exercise | F | 83.91 | 2,051 | 172,099 | 566,805 | 568.9 K to 566.8 K (-0.36 %) |
Oct 03 2018 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | President & CEO | Payment of Exercise | F | 61.52 | 2,050 | 126,116 | 566,805 | 568.9 K to 566.8 K (-0.36 %) |
Oct 03 2018 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | President & CEO | Payment of Exercise | F | 58.42 | 3,609 | 210,838 | 566,805 | 570.4 K to 566.8 K (-0.63 %) |
Sep 07 2018 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | Chief Medical Offic ... | Sell | S | 111.43 | 4,917 | 547,891 | 42,196 | 47.1 K to 42.2 K (-10.44 %) |
Jun 22 2018 | ICPT | INTERCEPT PHARMACE ... | SBLENDORIO GLENN | Director | Option Exercise | A | 85.12 | 2,748 | 233,910 | 2,748 | |
Jun 22 2018 | ICPT | INTERCEPT PHARMACE ... | SBLENDORIO GLENN | Director | Grant | A | 0.00 | 1,787 | 0 | 5,516 | 3.7 K to 5.5 K (+47.92 %) |
Jun 22 2018 | ICPT | INTERCEPT PHARMACE ... | AKKARAJU SRINIVAS | Director | Option Exercise | A | 85.12 | 2,748 | 233,910 | 2,748 | |
Jun 22 2018 | ICPT | INTERCEPT PHARMACE ... | AKKARAJU SRINIVAS | Director | Grant | A | 0.00 | 1,787 | 0 | 16,456 | 14.7 K to 16.5 K (+12.18 %) |
Jun 22 2018 | ICPT | INTERCEPT PHARMACE ... | SANTINI GINO | Director | Option Exercise | A | 85.12 | 2,748 | 233,910 | 2,748 | |
Jun 22 2018 | ICPT | INTERCEPT PHARMACE ... | SANTINI GINO | Director | Grant | A | 0.00 | 1,787 | 0 | 5,714 | 3.9 K to 5.7 K (+45.51 %) |
Jun 22 2018 | ICPT | INTERCEPT PHARMACE ... | Fundaro Paolo | Director | Option Exercise | A | 85.12 | 2,748 | 233,910 | 2,748 | |
Jun 22 2018 | ICPT | INTERCEPT PHARMACE ... | Fundaro Paolo | Director | Grant | A | 0.00 | 1,787 | 0 | 13,285 | 11.5 K to 13.3 K (+15.54 %) |
Jun 22 2018 | ICPT | INTERCEPT PHARMACE ... | WELCH DANIEL G | Director | Option Exercise | A | 85.12 | 2,748 | 233,910 | 2,748 | |
Jun 22 2018 | ICPT | INTERCEPT PHARMACE ... | WELCH DANIEL G | Director | Grant | A | 0.00 | 1,787 | 0 | 4,895 | 3.1 K to 4.9 K (+57.50 %) |
Jun 22 2018 | ICPT | INTERCEPT PHARMACE ... | Miller-Rich Nancy | Director | Option Exercise | A | 85.12 | 7,684 | 654,062 | 7,684 | |
Jun 22 2018 | ICPT | INTERCEPT PHARMACE ... | Miller-Rich Nancy | Director | Grant | A | 0.00 | 4,373 | 0 | 4,373 | 0 to 4.4 K |
Jun 22 2018 | ICPT | INTERCEPT PHARMACE ... | Gottesdiener Keith Michael | Director | Option Exercise | A | 85.12 | 2,748 | 233,910 | 2,748 | |
Jun 22 2018 | ICPT | INTERCEPT PHARMACE ... | Gottesdiener Keith Michael | Director | Grant | A | 0.00 | 1,787 | 0 | 6,788 | 5 K to 6.8 K (+35.73 %) |
Jun 22 2018 | ICPT | INTERCEPT PHARMACE ... | BRADBURY DANIEL | Director | Option Exercise | A | 85.12 | 2,748 | 233,910 | 2,748 | |
Jun 22 2018 | ICPT | INTERCEPT PHARMACE ... | BRADBURY DANIEL | Director | Grant | A | 0.00 | 1,787 | 0 | 13,429 | 11.6 K to 13.4 K (+15.35 %) |
Jun 22 2018 | ICPT | INTERCEPT PHARMACE ... | Benatti Luca | Director | Option Exercise | A | 85.12 | 2,748 | 233,910 | 2,748 | |
Jun 22 2018 | ICPT | INTERCEPT PHARMACE ... | Benatti Luca | Director | Grant | A | 0.00 | 1,787 | 0 | 6,356 | 4.6 K to 6.4 K (+39.11 %) |
Apr 09 2018 | ICPT | INTERCEPT PHARMACE ... | Gottesdiener Keith Michael | Director | Buy | P | 64.00 | 1,171 | 74,944 | 5,001 | 3.8 K to 5 K (+30.57 %) |
Apr 09 2018 | ICPT | INTERCEPT PHARMACE ... | Gottesdiener Keith Michael | Director | Buy | P | 64.00 | 1,171 | 74,944 | 5,001 | 3.8 K to 5 K (+30.57 %) |
Apr 09 2018 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | CEO & President | Buy | P | 64.00 | 7,812 | 499,968 | 576,564 | 568.8 K to 576.6 K (+1.37 %) |
Apr 09 2018 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | CEO & President | Buy | P | 64.00 | 7,812 | 499,968 | 576,564 | 568.8 K to 576.6 K (+1.37 %) |
Apr 09 2018 | ICPT | INTERCEPT PHARMACE ... | BRADBURY DANIEL | Director | Buy | P | 64.00 | 7,812 | 499,968 | 11,642 | 3.8 K to 11.6 K (+203.97 %) |